mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.39 |
0.0008 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0008 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.003 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.003 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.004 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |